Visalytics
Visalytics
approved EB-2 (NIW)

Research Scientist

Biomedicine · Iran · 2025-04-17

Processing Time
162 days
Decision Date
2025-04-17
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research in molecular biomedicine, specifically focusing on the development of nanoparticle-based delivery systems. His work aims to improve targeted cancer therapies, including chemotherapy, immunotherapy, and tumor thermal therapy, to enhance therapeutic efficacy while reducing side effects. The intended impact is to advance cancer care and oncology breakthroughs within the U.S. healthcare system.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research in nanoparticle-based delivery systems was found to be crucial to U.S. health priorities and cancer treatment.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 7 publications, 142 citations, and peer review work demonstrates his leadership and expertise in the field.

3 Balance of Interests Met

It was determined that the U.S. would benefit from waiving the labor certification due to the innovative nature of the petitioner's cancer research.

Why This Petition Was Approved

The petition was approved based on the petitioner's significant contributions to molecular biomedicine, including 7 peer-reviewed journal articles and 142 citations. His expertise was further evidenced by 7 peer reviews conducted for scientific journals and 2 first-authored conference abstracts. These achievements satisfied the Dhanasar prongs by demonstrating his leadership and the national importance of his innovative cancer treatment research.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Consultant

Biotechnology · Turkey

WeGreened EB-2 (NIW) approved
2 days 2023-08-24
The petitioner proposes to continue research on developing cutting-edge nanotherapeutic and nanotheranostic systems, as well as toxicology assays. This work focuses on improving cancer diagnosis and treatment while evaluating and reducing the toxicity of biomedical materials and devices.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 48 days 2025-09-04
The petitioner proposes to develop precision oncology tools by integrating nanotechnology, immunology, and computational methods to engineer next-generation cancer therapies. His work specifically focuses on designing personalized, neoantigen-based nano vaccines and SMART-lipid nanoparticles to improve immune system responsiveness and overcome tumor immune evasion.
View Case

Postdoctoral Researcher

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 309 days 2025-04-01
The petitioner proposes to continue research in the United States focused on synthesizing tumor-targeted nanocarriers for RNA therapeutic delivery and improving mRNA purification systems. This work aims to develop cost-effective and scalable solutions for cancer vaccines and RNA-based therapies. The endeavor is designed to address critical challenges in cancer therapy and vaccine manufacturing.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
North Carolina 132 days 2024-05-17
The petitioner proposes to continue her research in pharmaceutical sciences, specifically focusing on advancing drug repurposing and the development of nanoparticle-based delivery systems. Her work aims to create smarter, more efficient ways to deliver medications for critical diseases such as cancer and COVID-19. This research is intended to provide faster, cost-effective pathways for translating laboratory discoveries into viable clinical treatments.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 162 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist